Drug Trial Radar · NCT05031780
A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)
Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
286
Actual
Start
Feb 11, 2022
Primary completion
Oct 30, 2025
Study completion Feb 2030
Sponsor
- Lead sponsor
- Agios Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 2, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical trial is a Phase 2/3 study that will determine the recommended dose of mitapivat and evaluate the efficacy and safety of mitapivat in sickle cell disease by testing how well mitapivat works compared to placebo to increase the amount of hemoglobin in the blood and to reduce or prevent the occurrence of sickle cell pain crises. In addition, the long-term effect of mitapivat on efficacy and safety will be explored in an open-label extension portion.
Conditions
- Sickle Cell Disease
Interventions
MitapivatDrug
Mitapivat tablets
Mitapivat-matching placeboOther
Placebo to match 50 mg or 100 mg tablets
Mitapivat-matching placeboOther
Placebo to match 100 mg tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 2: Percentage of Participants With Hemoglobin (Hb) ResponseTime frame: Week 12
- Phase 2: Percentage of Participants With Treatment-Emergent Adverse Events (AEs) and Treatment-Emergent Serious AEs (SAEs)Time frame: Up to Week 12
- Phase 3: Percentage of Participants With Hb ResponseTime frame: Week 52
- Phase 3: Annualized Rate of Sickle Cell Pain Crises (SCPCs)Time frame: Up to Week 52
Locations
91 sites in 16 countries. Site status is shown where the registry gives one.
University of California San Diego
La Jolla, California
UCLA Health
Los Angeles, California
Children's Hospital Oakland
Oakland, California
University of Connecticut Health Center
Farmington, Connecticut
Children's National Hospital
Washington D.C., District of Columbia
MedStar Washington Hospital Center
Washington D.C., District of Columbia
Sylvester Comprehensive Cancer Center-Miami
Miami, Florida
University of Chicago Medical Center
Chicago, Illinois
Riley Hospital For Children
Indianapolis, Indiana
LSU Health Sciences Center - Shreveport
Shreveport, Louisiana
National Heart Lung and Blood Institute
Bethesda, Maryland
Kaiser Permanente - Largo Medical Center
Largo, Maryland
Massachusetts General Hospital
Boston, Massachusetts
Boston Children's Hospital
Boston, Massachusetts
Boston Medical Center & Boston University School of Medicine
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
Children's Hospital of Michigan
Detroit, Michigan
Southern Specialty Clinic
Flowood, Mississippi
Mississippi Center for Advanced Medicine
Madison, Mississippi
Cure 4 The Kids Foundation, A Division of Roseman University of Health Sciences
Las Vegas, Nevada
East Carolina University - Brody School of Medicine
Greenville, North Carolina
Penn Medicine - University of Pennsylvania Health System
Philadelphia, Pennsylvania
St. Christopher's Hospital for Children
Philadelphia, Pennsylvania
Lifespan at Rhode Island Hospital
Providence, Rhode Island
University of Texas Health Science Center of Houston
Houston, Texas
Texas Children's Hospital
Houston, Texas
Virginia Commonwealth University
Richmond, Virginia
Seattle Cancer Care Alliance, University of Washington
Seattle, Washington
ZAS Cadix
Antwerp, Belgium
CHR de la Citadelle
Liège, Belgium
Clinique CHC MontLégia
Liège, Belgium
Hôpital Erasme
Anderlecht, Brussels Capital, Belgium
Universitair Ziekenhuis Antwerpen
Edegem, Brussels Capital, Belgium
HEMORIO Instituto Nacional de Hematologia
Rio de Janeiro, Brazil
Hospital das Clínicas da Faculdade de Medicina da Universidad de São Paulo
São Paulo, Brazil
Multihemo Servicos Medicos S/A
Recife, Pernambuco, Brazil
Hospital de Clinicas de Porto Alegre (HCPA) - PPDS
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Sao Lucas Da Pontificia Universidade Catolica Do Rio Grande Do Sul (PUCRS)
Porto Alegre, Rio Grande do Sul, Brazil
Hospital de Clínicas da Unicamp
Campinas, São Paulo, Brazil
Hospital Das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP
Ribeirão Preto, São Paulo, Brazil
Showing 40 of 91 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.